Authors
Latest:
The Role of Transferable Skills and Data Science in the Move to Digitally-Enabled Clinical ResearchSimultaneous and niche skills sought amid evolution in clinical data management.
Latest:
Combating the ‘Talent Wars’ in BiopharmaCompetency-based and other creative approaches are needed to address the battle for talent in the clinical research workforce.
Latest:
Winning the Competition for Clinical Sites By Reducing Site User BurdenWith the number of clinical trials and sponsors increasing every year, meeting enrollment requirements and timelines becomes harder and harder. Please join Almac Clinical Technologies and Exostar as they discuss solutions to attract and retain the right resources to meet your requirements and timelines. Live: Thursday, Aug. 27, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Aug. 27, 2021.
Latest:
Reducing Patient Dropout Rates and Accelerating Trial CompletionJon Ernst (Vice President, In-Home Solutions, Decentralized Clinical Trials) discusses today's clinical trial landscape.
Latest:
The impact an eClinical Supply Chain Management platform can have on your next clinical trialSponsors and CROs have historically been responsible for ensuring full chain of custody for their own clinical supply even though the clinical supply is typically outside of their control. It is the burden of the Sponsors and CROs to determine the most efficient way to do that. An eClinical Supply Chain Management platform provides Sponsors and CROs with the assurance that they are meeting their regulatory requirement of full chain of custody and more importantly ensures that all needed clinical supplies are available and all samples get where and when they are needed.
Latest:
Harmonizing Outsourcing to Keep Clinical Trials on TrackA shared partnership culture is critical in navigating today’s complex terrain.
Latest:
Navigating the Future of Decentralized Clinical TrialsAlthough executive enthusiasm for decentralization of clinical trials has grown significantly, operationalizing these models requires meticulous planning and risk-based quality management.
Latest:
A Market Failure for Antimicrobial Resistant MedicinesWhile the world focuses on COVID-19, this article provides insight on the current state of the market for antimicrobial resistant (AMR) medicines.
Latest:
Challenges in Conducting Multicentric Infectious Giardia Diarrhea Clinical Studies in IndiaMulticentric studies on diarrhea are essential for comprehending its epidemiology, causes, and treatment outcomes.
Latest:
Oncolytic Virus Immunotherapy: A Brief Overview and Considerations for Clinical Trial PlanningSuccessful oncolytic virus immunotherapy clinical development requires unique features that focus on viral biology and host immune response.
Latest:
Clinical Trial Matching Solutions: Understanding the LandscapeA framework to understand the different approaches of trial matching solutions and the major operational and workflow challenges that all matching solutions share.
Latest:
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 DiabetesPhase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease, with benefits consistent with injectable semaglutide and other GLP-1 receptor agonists.
Latest:
Workforce Trends in Drug DevelopmentTufts CSDD study breaks down state of the talent pipeline from lens of senior leaders.
Latest:
Accelerate Inclusive Enrollment and Delivery with LightshipDavid MacMurchy, Chief Executive Officer at Lightship, offers some insights into the company's mission toward improving equity and diversity in clinical trials.
Latest:
De-Risking Trials with Science-Driven OversightIdentifying the ‘significant six’ areas of clinical study conduct to mitigate risk.
Latest:
When Should the Audit Trail Begin?A discussion of the regulatory history behind audit trails and its interpretation as it relates to clinical research data originating or residing in EDC or eCOA systems.
Latest:
R&D Using the Metaverse and Digital TwinsHow the digital environment can transform drug development space.
Latest:
PurpleLab Accelerates Clinical Trial Lifecycle with Real-World-DataJason Gagner (Vice President of Product for Life Science, PurpleLab) talks about clinical trial variables and how PurpleLab is working to maintain patient retention and accelerate site feasibility.
Latest:
Enhancing Empowerment in Patient-Focused ResearchHow the inclusion of measures centered on net treatment benefit can drive an effective multifaceted approach.
Latest:
Tailored Patient Involvement in Clinical TrialsThe approach of the Cancer Research UK Centre for Drug Development.
Latest:
Why and How to Infuse Methodological Rigor into Psychedelic Clinical TrialsRenewed interest in psychedelic research shows great promise for patients in need of more effective therapies.
Latest:
An Examination of the Use of Patient Recruitment and Retention Tactics for Global StudiesIn light of scant published data from sponsors and contract research organizations on site activation and recruitment challenges following the COVID-19 pandemic, the primary objective of this research is to revisit the results of recruitment and retention tactics in studies conducted in 2012 and 2019.
Latest:
Patient-Tested Practices for In-Home TrialsBringing clinical trials to patients’ homes can address existing site-based challenges.
Latest:
The Powerful Impact of Caregivers on Clinical TrialsConsidering caregiver-supported trials to improve patient retention and outcomes.
Latest:
How Clinical Trial Research Sites Can Gain Access to a More Level Playing FieldTo overcome sponsor-related challenges and work to successfully secure more trials, there are tactical steps CROs can take.
Latest:
The Eradication of False Signals in MonitoringHow optimizing RBQM risk detection reduces the efforts caused by false signals.
Latest:
Managing Clinical Trial AgreementsHow Clinical Research Malaysia sped up CTA turnaround using a web-based system.
Latest:
Introducing PALADINFirst-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
